StockData

BGM Group Ltd. (BGM) stock

BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026Score 9/30
$8.00−0.13 (-1.60%)

Close on Nov 19, 2026Market cap $3.21BP/E –Yield –

BGM net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$19.94M. The highest annual figure on record is $5.91M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$19.94M–
FY2024Sep 30, 2024-$1.44M–
FY2023Sep 30, 2023-$7.78M-822.6%
FY2022Sep 30, 2022$1.08M-65.9%
FY2021Sep 30, 2021$3.15M-37.7%
FY2020Sep 30, 2020$5.06M-14.3%
FY2019Sep 30, 2019$5.91M+13.6%
FY2018Sep 30, 2018$5.20M–

More BGM figures

See a number that looks wrong?